DLH Reports First Quarter Fiscal Year 2017 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
58
DLH Reports First Quarter Fiscal Year 2017 Results

ATLANTA, Feb. 08, 2017 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC ) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to Federal agencies, today announced financial results for its fiscal first quarter ended December 31, 2016. 

  • Revenue:  $26 million – up 58% over the first quarter of 2016, including 5% organic growth
  • Gross margin:  22.3% – an improvement of 470 basis points year-over-year
  • Diluted earnings per share: $0.03, versus $(0.01) in fiscal 2016
  • Senior debt reduced to $22.5 million
  • Expanded executive leadership, appointing Helene Fisher as President of Danya

Management Discussion “We got off to a good start in fiscal 2017, posting 5% organic revenue growth and another quarter of improving gross margins,” stated DLH President and Chief Executive Officer Zach Parker. “We continue to focus on business development initiatives and operational execution and, in that vein, were pleased to bring Helene Fisher on board as President of DLH Danya in December. Helene is a great addition to the Company and is already bringing a fresh approach to serving our civilian agency customers by leveraging our expanded, enterprise-wide capabilities. While bottom line results this quarter reflected some growth in management costs and non-cash stock compensation, we feel confident that DLH is on track for a very successful year. Given the current market environment - including a freeze on government hiring - we believe that demand for federal government outsourced expertise across key areas in the healthcare, IT, and veterans’ space will benefit DLH in the quarters and years to come.  DLH offers experienced staff with broad capabilities and technology-enabled solutions to deliver cost-competitive services to customers across its core markets.”

Results of Operations for the Three Months Ended December 31, 2016 Revenue for the three months ended December 31, 2016 was $26.1 million, an increase of $9.6 million, or 58%, over the prior year fiscal first quarter. The increase in revenue was due primarily to the acquisition of Danya on May 3, 2016 and continued expansion on existing contract vehicles.

For the three months ended December 31, 2016, gross profit was approximately $5.8 million, an increase of approximately $2.9 million, or 99%, year-over-year reflecting higher revenue and improved contract performance. As a percentage of revenue, the first quarter gross margin rate of 22.3% increased by 470 basis points compared to 17.6% gross margin in the prior year quarter. Favorable gross margin results were due principally to the contribution from Danya, more complex contracts, and effective cost management. The Company continues to focus on internal productivity measures to control costs and expand margins.

For the three months ended December 31, 2016, general and administrative (“G&A”) expenses were approximately $4.7 million, an increase of approximately $2.2 million, or 88%, over the prior year quarter. G&A expenses were approximately 18.1% of revenue, an increase of 2.9% over the fiscal first quarter of 2016. The increase in expenses was due primarily to the addition of expenses related to Danya, along with incremental program and operational resources to manage and grow DLH.  In addition, the fiscal 2017 quarter included non-cash stock compensation expense and yearly audit fees that totaled, in aggregate, approximately $0.7 million.

Income from operations for the three months ended December 31, 2016 was approximately $0.9 million, an increase of approximately $0.5 million, or 133%, over the prior year quarter. The improvement was primarily due to the contribution from Danya and expansion on legacy programs.

For the three months ended December 31, 2016, other expense, net, was approximately $0.4 million, a decrease of approximately $0.2 million over the prior year period. Other expense, net, includes interest expense and amortization of deferred financing costs on debt obligations, as well as other miscellaneous non-operational items.   For the prior year period, other expenses also included acquisition-related expenditures.

Net income for the three months ended December 31, 2016 was approximately $0.3 million, or $0.03 per diluted share, an increase of approximately $0.4 million, or $0.04 per share, over the prior year period.  The increase was due primarily to the operating contributions from Danya, net of interest and amortization of deferred financing expenses.

On a non-GAAP basis, Earnings Before Interest Tax Depreciation and Amortization (“EBITDA”) adjusted for other items (“Adjusted EBITDA”) for the three months ended December 31, 2016 was approximately $1.6 million, an improvement of approximately $0.8 million, or 115%, over the prior year three-month period. Growth was attributable to increased revenue and higher gross margins, as previously described. 

Balance Sheet Cash as of December 31, 2016 was $2.5 million, and the Company’s senior debt was $22.5 million.  Regarding cash flow, for the quarter ended December 31, 2016, cash provided by operating activities was $0.3 million.

Non-GAAP Financial Measures The Company believes that providing Income from Operations per share will be useful to investors in comparing year-over-year operating results for 2017 compared to 2016.  Income from Operations per share excludes the impact of other income (expense) and income tax benefits which may vary, sometimes significantly, from 2016 to 2017, independent of operating results.  By providing this non-GAAP measure, we believe that an investor can more easily compare year-over-year performance.

Reconciliation of GAAP earnings per share to Income from Operations per share, a non-GAAP measure (per-share amounts rounded):

    Three Months Ended
    December 31,
($ in thousands, except per share amounts)   2016       2015
Income from operations   $ 889         $ 382  
Other income (expense), net   (364 )       (575 )
Income before income taxes   525         (193 )
Income tax expense (benefit), net   201         (77 )
Net income   $ 324         $ (116 )
                 
Weighted-average outstanding shares fully diluted   12,690         9,568  
                 
Net income per fully diluted share   $ 0.03         $ (0.01 )
Income tax expense (benefit), net   0.02         (0.01 )
Income before taxes   $ 0.04         $ (0.02 )
Other income (expense), net   (0.03 )       (0.06 )
Income from operations per fully diluted share   $ 0.07         $ 0.04  
             

DLH uses Earnings Before Interest Tax Depreciation and Amortization (“EBITDA”) adjusted for other items (“Adjusted EBITDA”) as a supplemental non-GAAP measures of our performance. The Company defines Adjusted EBITDA as net income adjusted to exclude (i) interest and other expenses, including acquisition expenses, net, (ii) provision for or benefit from income taxes, if any, (iii) depreciation and amortization, and (iv) G&A expenses - equity grants.

This non-GAAP measure of performance is used by management to conduct and evaluate its business during its regular review of operating results for the periods presented. Management and the Company’s Board utilize these non-GAAP measures to make decisions about the use of the Company’s resources, analyze performance between periods, develop internal projections and measure management performance. The Company believes that these non-GAAP measures are useful to investors in evaluating ongoing operating and financial results and understanding how such results compare with the Company’s historical performance. By providing this non-GAAP measures as a supplement to GAAP information, management believes this enhances investors’ understanding of the Company's business and results of operations.

Reconciliation of GAAP net income to adjusted EBITDA, a non-GAAP measure:

    Three Months Ended
    December 31,
($ in thousands, except per share amounts)   2016   2015   Change
Net income (loss)   $ 324     $ (116 )   $ 440  
(i) Interest and other (income) expense (net):            
(i)(a) Interest and other expense   364         364  
(i)(b) Acquisition expenses       575     (575 )
(ii) Provision (benefit) for taxes   201     (77 )   278  
(iii) Depreciation and amortization   201     20     181  
(iv) G&A expenses - equity grants   485     332     153  
Adjusted EBITDA   $ 1,575     $ 734     $ 841  
             
Weighted-average outstanding shares fully diluted   12,690     9,568     3,122  
                   

During fiscal 2016, the Company acquired Danya International, LLC (“Danya”). DLH believes users of the Company’s financial statements may wish to evaluate the performance of the underlying business, excluding the impact of acquisitions. Therefore, the Company also provides organic revenue growth as a non-GAAP measure to support this objective.  To calculate organic revenue growth, the Company compares current year revenue less revenue from acquisitions to prior year revenue.

Conference Call and Webcast Details DLH management will discuss first quarter results in a conference call beginning at 11:00 AM Eastern Time on Wednesday, February 8, 2017.  Interested parties may listen to the conference call by dialing (844) 389-8659 and providing the operator with the conference ID 48891025.  Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.

A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing (855) 859-2056 and entering the conference ID 48891025.

About DLH DLH (NASDAQ: DLHC ) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. The Company's core competencies include assessment and compliance monitoring, business process outsourcing, health IT systems integration and management, readiness and medical logistics, and pharmacy solutions. DLH has over 1,400 employees working throughout the country. For more information, visit the corporate website at www.dlhcorp.com .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that are not statements of historical fact (including without limitation statements to the effect that the Company or its management "believes", "expects", "anticipates", "plans", “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH`s actual results to differ materially from those indicated by the forward-looking statements. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2016. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

TABLES TO FOLLOW

DLH HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands except per share amounts)
 
    (unaudited)
    Three Months Ended
    December 31,
    2016   2015
Revenue   $ 26,111     $ 16,559  
Direct expenses   20,300     13,642  
Gross margin   5,811     2,917  
General and administrative expenses   4,721     2,515  
Depreciation and amortization   201     20  
Income from operations   889     382  
Other income (expense), net   (364 )   (575 )
Income before income taxes   525     (193 )
Income tax expense (benefit), net   201     (77 )
Net income   $ 324     $ (116 )
         
Net income per share - basic   $ 0.03     $ (0.01 )
Net income per share - diluted   $ 0.03     $ (0.01 )
         
Weighted average common shares outstanding        
Basic   11,201     9,568  
Diluted   12,690     9,568  
             
DLH HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands except par value of shares)
 
    December 31,  2016   September 30,  2016
    (unaudited)   (audited)
ASSETS        
Current assets:        
Cash and cash equivalents   $ 2,471     $ 3,427  
Accounts receivable, net   7,292     6,637  
Other current assets   625     542  
Total current assets   10,388     10,606  
Equipment and improvements, net   600     644  
Deferred taxes, net   11,415     11,415  
Goodwill and other intangible assets, net   42,438     42,304  
Other long-term assets   105     105  
Total assets   $ 64,946     $ 65,074  
         
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Current liabilities:        
Debt obligations - current   $ 3,570     $ 3,560  
Derivative financial instruments, at fair value   283     204  
Accrued payroll   3,790     3,616  
Accounts payable, accrued expenses, and other current liabilities   6,948     7,136  
Total current liabilities   14,591     14,516  
Total long term liabilities   17,768     18,782  
Total liabilities   32,359     33,298  
Commitments and contingencies        
Shareholders' equity:        
Preferred stock, $.10 par value; authorized 5,000 shares, none issued and outstanding        
Common stock, $.001 par value; authorized 40,000 shares; issued and outstanding 11,242 at December 31, 2016 and 11,148 at September 30, 2016   11     11  
Additional paid-in capital   82,384     81,897  
Accumulated deficit   (49,808 )   (50,132 )
Total shareholders’ equity   32,587     31,776  
Total liabilities and shareholders' equity   $ 64,946     $ 65,074  
                 

 

CONTACTS: COMMUNICATIONS Contact: Tiffany McCall Phone: 404-334-6000 x1799 Email: tiffany.mccall@dlhcorp.com INVESTOR RELATIONS Contact: Chris Witty Phone: 646-438-9385 Email: cwitty@darrowir.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Growth of Graphic Packaging Holding Stock

Updated Category News Views 143

Investment Overview of Graphic Packaging Holding Graphic Packaging Holding Co (NYSE: GPK) has demonstrated impressive growth over the last two decades, surpassing market averages with an annualized return of 10.07%. The company's market capitalization currently stands at $5.95 billion, reflecting its significant presence in the packaging industry. Initial Investment Value...

Continue Reading
Celebrating Innovation: Haier's Partnership With Roland-Garros

Updated Category News Views 192

Haier and Roland-Garros: A Partnership Built on Excellence As the prestigious Roland-Garros tournament unfolds, the iconic clay courts come alive with energy, highlighting the shared values of excellence and innovation between Haier and this celebrated event. Introduced in 2023, this strategic partnership marks its third year, reinforcing both entities' commitment to...

Continue Reading
Swiss Franc's Rise and Its Impact on Trading Strategies

Updated Category News Views 179

The Appeal of the Swiss Franc in Carry Trades Investors are increasingly turning to the Swiss franc as a viable alternative to Japan's yen for carry trades, but the currency's potential for swift rallies remains a key concern. The Swiss franc has long been a favorite in carry trading, a strategy where traders borrow currencies with lower interest rates and convert them...

Continue Reading
LGCY Power Grows Solar Offerings by Partnering with Homebuilders

Updated Category News Views 305

LGCY Power Strategically Partners with Builders to Expand LGCY Power, recognized as a top-ranked solar installation company in the U.S., is taking significant strides to grow its residential solar business. The company has recently forged partnerships with national homebuilders to provide innovative solar solutions for new home constructions. This strategic move reflects...

Continue Reading
Deep Dive into Lockheed Martin's Options Trading Insights

Updated Category News Views 95

Understanding the Trends in Lockheed Martin's Options Market Lockheed Martin (LMT) is drawing significant attention from investors, particularly with a bearish sentiment prevailing among large-scale traders. This observation encourages retail investors to pay close attention to the unfolding dynamics within the options market for this defense giant. Recent tracking of...

Continue Reading